Tesamorelin 5mg
Stabilised GHRH analogue (trans-3-hexenoyl-GRF 1-44)
≥99.0%
Third-Party
COA
Also available in 10mg · 20mg — compare all sizes
Complete your research kit
Also searched as: TH9507
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
Tesamorelin 5mg is a lyophilised research peptide supplied for laboratory and scientific investigation. Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), studied primarily for its interaction with the GHRH receptor and downstream growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signalling. For Australian researchers, Tesamorelin 5mg provides a single-peptide format for controlled experimental work involving endocrine, metabolic and growth hormone-related pathways.
What Is Tesamorelin 5mg?
Tesamorelin is a synthetic peptide based on the biologically active sequence of human GHRH. It consists of 44 amino acids and incorporates a modification intended to improve stability compared with naturally occurring GHRH.
In experimental models, Tesamorelin acts as a GHRH receptor agonist. Activation of these receptors on pituitary somatotroph cells stimulates signalling associated with growth hormone synthesis and release.
This mechanism makes Tesamorelin peptide research relevant to investigations of the GH/IGF-1 axis, endocrine regulation and related metabolic signalling.
Key Research Areas
Why Researchers Study Tesamorelin
Tesamorelin is scientifically interesting because of its position within the growth hormone signalling pathway. Rather than directly supplying growth hormone, it activates GHRH receptors involved in regulating endogenous GH secretion.
This provides researchers with a way to investigate receptor activation, pituitary signalling and downstream IGF-1 pathways.
Tesamorelin 5mg is also a single-compound preparation rather than a peptide blend, allowing GHRH receptor activity to be investigated without introducing additional compounds targeting separate receptor systems.
Key Research Areas at a Glance
Tesamorelin 5mg in Australia
Researchers searching for Tesamorelin 5mg Australia should consider product documentation, batch traceability and analytical testing when comparing suppliers.
Before purchasing Tesamorelin 5mg online in Australia, confirm current availability, listed price, domestic shipping arrangements and whether batch-specific analytical documentation is provided.
Tesamorelin should be purchased and handled strictly within an appropriate laboratory or scientific research setting.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Tesamorelin 5mg is supplied as a lyophilised peptide preparation with a nominal quantity of 5mg per vial.
Researchers should review available batch documentation before experimental use. Relevant documentation may include analytical purity results, identity testing and a batch-specific Certificate of Analysis (CoA), where provided.
Methods such as HPLC and mass spectrometry are commonly used for peptide analysis. However, the specific purity and testing methods for an individual batch should always be confirmed from its documentation.
Analytical purity does not establish clinical safety or therapeutic effectiveness.
Storage & Handling
Storage and Laboratory Handling
- Lyophilised Storage: Follow the verified storage conditions stated on the product label or corresponding batch documentation.
- After Reconstitution: Researchers should follow validated laboratory procedures and available batch-specific documentation.
Where post-reconstitution stability has not been established for a particular batch, researchers should not assume an unsupported storage period or condition.
Reconstitution calculator: Tesamorelin 5mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
Tesamorelin 5mg: Frequently Asked Questions
Tesamorelin 5mg is a lyophilised synthetic GHRH analogue supplied as a single-peptide material for laboratory research.
Tesamorelin activates GHRH receptors involved in pituitary growth hormone signalling and downstream IGF-1 pathways.
Its principal experimental target is the growth hormone-releasing hormone receptor (GHRHR), particularly on pituitary somatotroph cells.
Research has examined growth hormone signalling, IGF-1 pathways, endocrine regulation, lipid metabolism and body-composition mechanisms.
Purity and analytical testing should be confirmed from documentation supplied for the specific Tesamorelin 5mg batch.
CoA availability depends on the supplier and batch. Researchers should review batch-specific analytical documentation where provided.
Follow storage requirements stated on the product label or batch documentation. After reconstitution, follow validated laboratory protocols.
Tesamorelin 5mg may be available from Australian research peptide suppliers. Researchers should check stock, price, testing documentation and domestic shipping before ordering.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
Tesamorelin is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.